1842 / 1851
4 out of 10 patients with cancer who are cured by
treatment receive radiotherapy.
Combining novel drugs with RT has clear potential to
significantly improve patient outcomes.
When companies are considering testing a novel
combination for an agent, they should consider drug–RT
combinations as important as drug–drug combinations
.
Sharma RA et al. Nature Reviews Clin Oncol 2016;13:627-